[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Ventilator Associated Pneumonia (VAP)-Therapeutics Market Research Report 2021

August 2016 | 100 pages | ID: G9E386AD35FEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Ventilator Associated Pneumonia (VAP)-Therapeutics

Revenue, means the sales value of Ventilator Associated Pneumonia (VAP)-Therapeutics

This report studies Ventilator Associated Pneumonia (VAP)-Therapeutics in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
  • Adenium Biotech
  • Aridis Pharmaceuticals
  • AstraZeneca
  • Merck
  • Cardeas Pharma
  • Dong-A Socio
  • MedImmune
  • Meiji Seika Pharma
  • Nabriva Therapeutics
  • Tetraphase Pharmaceuticals
  • Serendex Pharmaceuticals
  • Savara Pharmaceuticals
Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Ventilator Associated Pneumonia (VAP)-Therapeutics in these regions, from 2011 to 2021 (forecast), like
  • North America
  • China
  • Europe
  • Japan
  • India
  • Southeast Asia
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Ventilator Associated Pneumonia (VAP)-Therapeutics in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Ventilator Associated Pneumonia (VAP)-Therapeutics Market Research Report 2021

1 VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Ventilator Associated Pneumonia (VAP)-Therapeutics
1.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Segment by Types
  1.2.1 Global Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Segment by Applications
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Ventilator Associated Pneumonia (VAP)-Therapeutics Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Ventilator Associated Pneumonia (VAP)-Therapeutics (2011-2021)
  1.5.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Revenue (2011-2021)
  1.5.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
  1.5.3 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

2 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Ventilator Associated Pneumonia (VAP)-Therapeutics Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS ANALYSIS BY REGION

3.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Region (2011-2021)
  3.1.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
  3.2.2 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
  3.4.2 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
  3.6.2 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS ANALYSIS BY TYPE

4.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type (2011-2021)
  4.1.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type I Sales, Revenue, Price and Growth (2011-2020)
4.3 Type II Sales, Revenue, Price and Growth (2011-2020)
4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS MARKET ANALYSIS BY APPLICATION

5.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Application (2011-2021)
5.2 Major Regions Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application in 2015 and 2016
  5.2.1 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application
  5.2.2 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application
  5.2.3 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application
  5.2.4 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application
  5.2.5 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application
  5.2.6 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application

6 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS MANUFACTURERS ANALYSIS

6.1 Adenium Biotech
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.1.2.1 Type I
    6.1.2.2 Type II
    6.1.2.3 Type III
  6.1.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Adenium Biotech (2015 and 2016)
6.2 Aridis Pharmaceuticals
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.2.2.1 Type I
    6.2.2.2 Type II
    6.2.2.3 Type III
  6.2.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
6.3 AstraZeneca
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.3.2.1 Type I
    6.3.2.2 Type II
    6.3.2.3 Type III
  6.3.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of AstraZeneca (2015 and 2016)
6.4 Merck
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.4.2.1 Type I
    6.4.2.2 Type II
  6.4.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Merck (2015 and 2016)
6.5 Cardeas Pharma
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.5.2.1 Type I
    6.5.2.2 Type II
  6.5.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Cardeas Pharma (2015 and 2016)
6.6 Dong-A Socio
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.6.2.1 Type I
    6.6.2.2 Type II
  6.6.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Dong-A Socio (2015 and 2016)
6.7 MedImmune
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.7.2.1 Type I
    6.7.2.2 Type II
  6.7.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of MedImmune (2015 and 2016)
6.8 Meiji Seika Pharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.8.2.1 Type I
    6.8.2.2 Type II
  6.8.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Meiji Seika Pharma (2015 and 2016)
6.9 Nabriva Therapeutics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.9.2.1 Type I
    6.9.2.2 Type II
  6.9.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Nabriva Therapeutics (2015 and 2016)
6.10 Tetraphase Pharmaceuticals
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview
    6.10.2.1 Type I
    6.10.2.2 Type II
  6.10.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Tetraphase Pharmaceuticals (2015 and 2016)
6.11 Serendex Pharmaceuticals
6.12 Savara Pharmaceuticals

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Ventilator Associated Pneumonia (VAP)-Therapeutics
Figure Global Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Type in 2015
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type of by Manufacturers
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Application in 2015 and 2016
Figure North America Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure China Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure India Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Revenue (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Manufacturers
Figure 2016 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Manufacturers
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue by Manufacturers (2015 and 2016)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Manufacturers
Table 2016 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Manufacturers
Table Manufacturers Ventilator Associated Pneumonia (VAP)-Therapeutics Manufacturing Base Distribution and Product Type
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market by Region (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market by Region (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Region (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Market by Region (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Market Share by Region (2011-2021)
Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
Figure North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
Figure Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
Figure China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
Figure Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
Figure India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Type (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Type (2011-2021)
Figure Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Type (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Growth Rate by Type (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue by Type (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Type (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Growth Rate by Type (2011-2021)
Figure Type I Sales, Revenue and Growth (2011-2021)
Figure Type I Price Trend (2011-2021)
Figure Type II Sales, Revenue and Growth (2011-2021)
Figure Type II Price Trend (2011-2021)
Figure Type III Sales, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Application (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Application in 2015
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Application in 2021
Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)
Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)
Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)
Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)
Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)
Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Growth Rate by Application (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Growth Rate by Application (2011-2021)
Table Adenium Biotech Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Adenium Biotech (2015 and 2016)
Table Aridis Pharmaceuticals Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
Table AstraZeneca Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Merck Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Merck (2015 and 2016)
Table Cardeas Pharma Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Cardeas Pharma (2015 and 2016)
Table Dong-A Socio Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Dong-A Socio (2015 and 2016)
Table MedImmune Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of MedImmune (2015 and 2016)
Table Meiji Seika Pharma Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Meiji Seika Pharma (2015 and 2016)
Table Nabriva Therapeutics Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Nabriva Therapeutics (2015 and 2016)
Table Tetraphase Pharmaceuticals Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Tetraphase Pharmaceuticals (2015 and 2016)
Table Serendex Pharmaceuticals Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Serendex Pharmaceuticals (2015 and 2016)
Table Savara Pharmaceuticals Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Savara Pharmaceuticals (2015 and 2016)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories